How did Opus Genetics' revenue and expenses shift in Q4 2024?

Opus Genetics' revenue and expenses in Q4 2024 showed a significant shift, with a notable increase in revenue and a corresponding rise in operating expenses, resulting in a gross margin of 100% and a net income of -$35.14 million. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |IRD|IRD.O|Opus Genetics|20240101-2024|Collaborations|1.0992E7|186| |IRD|IRD.O|Opus Genetics|20240101-2024|Collaborations|6690000|186| |IRD|IRD.O|Opus Genetics|20240101-2024|Collaborations|2823000|186| |IRD|IRD.O|Opus Genetics|20240101-2024|Collaborations|1711000|186| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |IRD|IRD.O|Opus Genetics|2024 Q1|-22.70764980141599|-7106000|186| |IRD|IRD.O|Opus Genetics|2024 Q2|-56.520862729288446|-7765000|186| |IRD|IRD.O|Opus Genetics|2024 Q3|-235.33537133609062|-7526000|186| |IRD|IRD.O|Opus Genetics|2024 Q4|-632.7424400417101|-3.5135E7|186| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |IRD|IRD.O|Opus Genetics|2024 Q1|-2.172670097198399|1711000|186| |IRD|IRD.O|Opus Genetics|2024 Q2|-69.73326075122482|1112000|186| |IRD|IRD.O|Opus Genetics|2024 Q3|-67.59949727691664|3867000|186| |IRD|IRD.O|Opus Genetics|2024 Q4|154.40567711413365|4302000|186| |code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code| |---|---|---|---|---|---|---| |IRD|IRD.O|Opus Genetics|2024 Q1|100|0|186| |IRD|IRD.O|Opus Genetics|2024 Q2|100|0|186| |IRD|IRD.O|Opus Genetics|2024 Q3|100|0|186| |IRD|IRD.O|Opus Genetics|2024 Q4|100|0|186|